Friedhelm Leverkus | Director Health Technology Assessment And Outcomes Research
Pfizer

Friedhelm Leverkus, Director Health Technology Assessment And Outcomes Research, Pfizer

Appearances:



Day 2- Fri 25th September 2020 @ 16:25

Registries for orphan drugs in the German AMNOG process

last published: 03/Jun/20 15:55 GMT

back to speakers

Contact us

To sponsor or exhibit:
Edmond Rama
+44 (0)207 092 1052

edmond.rama@terrapinn.com

To speak:
Chris Shanks
+44 (0)207 092 1151

chris.shanks@terrapinn.com